New Millennium Group’s Cardinal Health CAH Stock Holding History

New Millennium Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14	Closed	-$1.93K	–	443
2025 Q1	$1.93K	Buy	+14	New	+$1.78K	﹤0.01%	337

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New Millennium Group's CAH Position: Q2 2025 in Review

New Millennium Group sold out of Cardinal Health (CAH) in Q2 2025, closing a stake of 14 shares — an estimated $1.93K sold.

New Millennium Group first reported a position in CAH in Q1 2025 and held it in 1 quarter. The position peaked at $1.93K in Q1 2025. 1,253 funds tracked by Wall St. Rank hold CAH as of Q2 2025.

New Millennium Group reported no remaining Cardinal Health position as of Q2 2025 after selling out during the quarter.
New Millennium Group sold 14 Cardinal Health shares in Q2 2025, an estimated $1.93K.
New Millennium Group first reported a position in Cardinal Health in Q1 2025 and held it in 1 quarter.
New Millennium Group's Cardinal Health position peaked at $1.93K in Q1 2025.
1,253 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2025.

Based on New Millennium Group's 13F filing for Q2 2025, filed 6 Aug 2025.